Valens Company Inc (The) Ordinary Shares VLNCF

The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada and other countries, and it generates a majority of revenue from the Cannabis operations segment.

OTCQX:VLNCF - Post by User

Valens Company Inc (The) Ordinary Shares

<< Previous

Bullboard Posts

Next >>

Post by Betteryear2on Apr 13, 2022 7:38pm

189 Views

Post# 34602278

First Quarter Fiscal 2022 Financial Results TSX: VLNS

Net revenue grew 26.1% quarter over quarter to $23.2 million from $18.4 million in Q4 2021. Net revenue was primarily driven by provincial sales which increased by 36.7% in Q1 2022 as compared to Q4 2021

Q1 2022 demonstrates Valens' underlying business has passed an inflection point

Became a top 10 licensed producer in Canada, with a 3.1% market share as of February 2022

B2C revenue lines of provincial sales and Green Roads accounted for 68.5% of net revenue in Q1 2022

Valens reiterates its objective of achieving positive adjusted EBITDA by Q4 2022

KELOWNA, BC, April 13, 2022 /CNW/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to report its first quarter fiscal year 2022 financial results for the period ended February 28, 2022.